UnitedHealth Group Inc (NYSE:UNH) to Post Q2 2020 Earnings of $3.93 Per Share, Piper Sandler Forecasts

UnitedHealth Group Inc (NYSE:UNH) – Analysts at Piper Sandler cut their Q2 2020 earnings per share estimates for shares of UnitedHealth Group in a note issued to investors on Wednesday, January 15th. Piper Sandler analyst S. James now forecasts that the healthcare conglomerate will post earnings of $3.93 per share for the quarter, down from their previous estimate of $3.97. Piper Sandler also issued estimates for UnitedHealth Group’s Q3 2020 earnings at $4.43 EPS, Q4 2020 earnings at $4.50 EPS, FY2020 earnings at $16.45 EPS and Q1 2021 earnings at $4.61 EPS.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Wednesday, January 15th. The healthcare conglomerate reported $3.90 EPS for the quarter, topping analysts’ consensus estimates of $3.77 by $0.13. The business had revenue of $60.90 billion during the quarter, compared to the consensus estimate of $61.17 billion. UnitedHealth Group had a return on equity of 25.30% and a net margin of 5.57%. The business’s revenue for the quarter was up 4.3% on a year-over-year basis. During the same period in the prior year, the firm posted $3.28 EPS.

Several other brokerages also recently issued reports on UNH. Stephens increased their price target on UnitedHealth Group from $325.00 to $333.00 and gave the company an “overweight” rating in a report on Wednesday. UBS Group increased their price target on UnitedHealth Group from $279.00 to $304.00 and gave the company a “neutral” rating in a report on Thursday. JPMorgan Chase & Co. increased their price target on UnitedHealth Group from $276.00 to $361.00 and gave the company an “overweight” rating in a report on Friday, December 20th. Credit Suisse Group boosted their price target on UnitedHealth Group from $320.00 to $330.00 and gave the stock an “outperform” rating in a research report on Wednesday, January 8th. Finally, Raymond James upped their price target on UnitedHealth Group from $300.00 to $320.00 and gave the stock a “buy” rating in a report on Thursday, December 5th. Five equities research analysts have rated the stock with a hold rating and nineteen have given a buy rating to the stock. The stock presently has a consensus rating of “Buy” and an average target price of $313.50.

UNH stock opened at $300.74 on Friday. The company has a market cap of $273.08 billion, a price-to-earnings ratio of 23.35, a PEG ratio of 1.37 and a beta of 0.65. The company has a quick ratio of 0.70, a current ratio of 0.70 and a debt-to-equity ratio of 0.67. The business has a fifty day simple moving average of $288.85 and a 200-day simple moving average of $255.32. UnitedHealth Group has a 52 week low of $208.07 and a 52 week high of $300.99.

In other UnitedHealth Group news, CAO Thomas E. Roos sold 1,177 shares of the firm’s stock in a transaction on Thursday, November 7th. The shares were sold at an average price of $255.04, for a total transaction of $300,182.08. Following the completion of the transaction, the chief accounting officer now directly owns 21,687 shares of the company’s stock, valued at approximately $5,531,052.48. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, EVP D Ellen Wilson sold 7,400 shares of the firm’s stock in a transaction dated Monday, November 18th. The stock was sold at an average price of $272.77, for a total transaction of $2,018,498.00. Corporate insiders own 0.87% of the company’s stock.

Institutional investors have recently bought and sold shares of the company. Selective Wealth Management Inc. bought a new position in shares of UnitedHealth Group in the 3rd quarter worth about $27,000. North Star Investment Management Corp. bought a new position in shares of UnitedHealth Group in the 3rd quarter worth about $30,000. Delta Asset Management LLC TN lifted its position in shares of UnitedHealth Group by 111.0% in the 3rd quarter. Delta Asset Management LLC TN now owns 154 shares of the healthcare conglomerate’s stock worth $33,000 after buying an additional 81 shares during the last quarter. Fusion Family Wealth LLC lifted its position in shares of UnitedHealth Group by 329.7% in the 3rd quarter. Fusion Family Wealth LLC now owns 159 shares of the healthcare conglomerate’s stock worth $35,000 after buying an additional 122 shares during the last quarter. Finally, Massey Quick Simon & CO. LLC lifted its position in shares of UnitedHealth Group by 212.5% in the 3rd quarter. Massey Quick Simon & CO. LLC now owns 175 shares of the healthcare conglomerate’s stock worth $38,000 after buying an additional 119 shares during the last quarter. Institutional investors own 85.44% of the company’s stock.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.

Read More: What is the Shanghai Stock Exchange Composite Index?

Earnings History and Estimates for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.